SciELO - Scientific Electronic Library Online

 
vol.55 número3The perception of educational assistants and medicine students of the clinical cycle of the FCM-UNA medicine career, on the teaching and learning process of the clinical methodAttitudes, knowledge and behaviors about salt consumption according to the perception of a group of women in Paraguay índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Anales de la Facultad de Ciencias Médicas (Asunción)

versão impressa ISSN 1816-8949

Resumo

RICO FONTALVO, Jorge et al. Update on diabetic kidney disease. An. Fac. Cienc. Méd. (Asunción) [online]. 2022, vol.55, n.3, pp.86-98. ISSN 1816-8949.  https://doi.org/10.18004/anales/2022.055.03.86.

Introduction:

Diabetes mellitus (DM) is a systemic inflammatory disease of high prevalence and incidence worldwide. Among the chronic complications, diabetic kidney disease is one of the most frequent and determines the prognosis.

Objectives:

The objective of this article is to make an updated review of diabetic kidney disease, in light of the changes in the paradigms that have been generated in recent years concerning to the new definitions, the role of inflammation-causing disease, cardiovascular risk management, and the new treatments. Diabetic kidney disease can present in approximately 30-50% of the population with diabetes mellitus type 1 or 2 around the world. In the pathogenesis and progression of this condition, three fundamental axes are distinguished: the hemodynamic, the metabolic, and the inflammatory. It is important to manage cardiovascular risk. The diagnosis must be made by calculating the glomerular filtration rate and the albuminuria/creatinuria ratio in a random urine sample. The objectives of the treatment should be: metabolic control, reduce or slow the progression of kidney disease and improve cardiovascular outcomes.

Conclusion:

The treatment of diabetic kidney disease should be holistic, from non-pharmacological interventions, such as lifestyle changes, to new medications such as the use of SGLT-2 inhibitors, GLP-1 receptor agonists, and the use of selective mineralocorticoid receptor antagonists such as finerenone. The future is promising.

Palavras-chave : Diabetes; kidney disease; cardiovascular risk; glomerular filtration rate; guides; holistic..

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )